Skip to content

Effects of Exercise During a 2-Week Low Carbohydrate Diet on Lipid Profile: A Randomized Controlled Trial

Effects of Exercise During a 2-Week Low Carbohydrate Diet on Lipid Profile: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009982
Enrollment
28
Registered
2024-12-02
Start date
2024-11-04
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral, Others : 1. Distinction and Main Differences Between Intervention Groups Dietary Intervention Group: Participants will follow a low-carbohydrate diet for two weeks. The diet consists of 70

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy adult men and women aged 18-50 years old For men, a body mass index (BMI) of less than 25 kg/m2 or a body fat percentage of less than 20 per cent. For women, a body mass index (BMI) of less than 25 kg/m2 or a body fat percentage of less than 25 per cent. The Physical Activity Readiness Questionnaire for Everyone (PAR-Q) indicates that you are fit to perform physical activity. Able to run for 30 minutes at an intensity of 60-70% of their maximum heart rate (220 - age). Able to perform bodyweight-based strength training exercises. Understand all experimental procedures performed in this study and agree to participate in the study.

Exclusion criteria

Exclusion criteria: Do not agree to participate in this study Have experienced a weight change (± 3kg) in the last 6 months Have been following a ketogenic diet for the past 6 months Do more than 300 minutes of aerobic exercise (excluding walking) per week Have chronic medical conditions (hypertension, diabetes, hyperlipidaemia, etc.) Have a physician diagnosis of cardiovascular disease other than hypertension (angina pectoris, myocardial infarction, heart failure, stroke, cerebral haemorrhage, occlusive peripheral vascular disease) or are taking medication to treat a related condition. - Those taking lipid-lowering medications (statins, fibrates, omega-3s, etc.) should discontinue them 4 weeks prior to the event. Patients with liver and kidney failure People taking hormone-related treatments or medication People with a history of chest pain during exercise or physical activity Musculoskeletal disorders that make it difficult to perform sustained running or strength training. Any other condition that, in the opinion of the principal investigator, would make it difficult for the patient to participate in the study.

Design outcomes

Primary

MeasureTime frame
low density lipoprotein cholesterol subfraction

Secondary

MeasureTime frame
Lipid profile (total cholesterol, triglycerides, HDL-C, LDL-C, Lipo(a), ApoA1, APoB);Related to glucose metabolism (fasting glucose, fasting insulin, fasting C-peptide, glycocalbumin);Ketone bodies and fatty acids (beta-hydroxybutyrate, free fatty acid-fasting);Complete blood count (WBC, RBC, hemoglobin, hematocrit, platelets);Inflammatory markers (c-reactive protein);Exercise tests (VO2max test, 1RM test)

Countries

Korea, Republic of

Contacts

Public ContactEun Chan Kim

Yonsei University

yhv777@naver.com+82-2-2123-6165

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jul 23, 2026